Keyphrases
Antimalarial Drug Resistance
100%
Artemisinin Resistance
100%
Plasmodium Falciparum
100%
Piperaquine Resistance
60%
Dihydroartemisinin-piperaquine
60%
Molecular Markers
40%
Multidrug-resistant
40%
Greater Mekong Subregion
40%
Artemisinin-based Combination Therapy
40%
Malaria Chemotherapy
20%
Molecular Resistance Mechanism
20%
African Setting
20%
Sentinel Sites
20%
Piperaquine
20%
Partner Drug
20%
Mass Drug Administration
20%
Frontline Treatment
20%
Molecular Genomics
20%
Resistance Evolution
20%
Artemisinin
20%
Molecular Mechanism
20%
Falciparum Malaria
20%
Drug-resistant Parasites
20%
Parasite Clearance
20%
Global Concern
20%
South-East Asia
20%
Population Genomics
20%
Malaria
20%
Genomic Approaches
20%
Curb
20%
K13 Gene
20%
Clinical Resistance
20%
Clinical Phenotype
20%
Pharmacology, Toxicology and Pharmaceutical Science
Artemisinin
100%
Drug Resistance
100%
Antimalarial Agent
100%
Piperaquine
85%
Dihydroartemisinin
42%
K 13
42%
Combination Therapy
28%
Molecular Marker
28%
Drug Administration
14%
Parasite Clearance
14%
Artemisinin Derivative
14%
Malaria Falciparum
14%
Plasmodium falciparum
14%
Chemotherapy
14%